chlorpromazine has been researched along with Delusional Disorder in 71 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A combined analysis of data from 11 controlled studies of loxapine versus either chlorpromazine or trifluoperazine in acute schizophrenia (5 studies) and chronic schizophrenia (6 studies) showed statistically significant superiority of loxapine on several items and factors of standardized psychiatric rating scales." | 9.04 | Efficacy of loxapine in the treatment of paranoid schizophrenia. ( Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM, 1977) |
| "We report the case of a 50-year-old man, treated with chlorpromazine for schizophrenia, who developed an agranulocytosis." | 7.75 | [Chlorpromazine-induced agranulocytosis: a case report]. ( Guillin, O; Kerleau, JM; Petit, M; Podlipski, MA; Stephan, F, 2009) |
| "Loxapine succinate was compared to chlorpromazine in a 12-week double-blind study of 50 hospitalized chronic schizophrenic patients." | 6.64 | Loxapine succinate: a controlled double-blind study in chronic schizophrenia. ( Schiele, BC, 1975) |
| "A combined analysis of data from 11 controlled studies of loxapine versus either chlorpromazine or trifluoperazine in acute schizophrenia (5 studies) and chronic schizophrenia (6 studies) showed statistically significant superiority of loxapine on several items and factors of standardized psychiatric rating scales." | 5.04 | Efficacy of loxapine in the treatment of paranoid schizophrenia. ( Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM, 1977) |
| "We report the case of a 50-year-old man, treated with chlorpromazine for schizophrenia, who developed an agranulocytosis." | 3.75 | [Chlorpromazine-induced agranulocytosis: a case report]. ( Guillin, O; Kerleau, JM; Petit, M; Podlipski, MA; Stephan, F, 2009) |
| "Agranulocytosis developed in three patients subsequent to chlorpromazine therapy and in one patient following treatment with methotrimeprazine and trifluoperazine." | 3.67 | Agranulocytosis in the course of phenothiazine therapy: case reports. ( Yassa, R, 1985) |
| "The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and photosensitivity after the addition of propranolol to her neuroleptic regimen." | 3.66 | Adverse effects of combined propranolol and chlorpromazine therapy. ( Miller, FA; Rampling, D, 1982) |
| "Clinical experience gained in the Soviet Union shows that Triphthazine (Trifluoperazine) is among the most useful drugs for mass treatment of psychoses." | 3.65 | [Use of triphthazine in the treatment of mentae disorders]. ( Awruzki, GJ; Gurowitsch, IJ, 1975) |
| "Loxapine succinate was compared to chlorpromazine in a 12-week double-blind study of 50 hospitalized chronic schizophrenic patients." | 2.64 | Loxapine succinate: a controlled double-blind study in chronic schizophrenia. ( Schiele, BC, 1975) |
| "Chlorpromazine was stopped due to concern of NMS." | 1.46 | Neuroleptic malignant syndrome with thyroid disorder: An unusual case report. ( Goldman, J; Kanzali, P; Paras, C; Rubin, V; Zhang, F, 2017) |
| "A group of patients with paranoid schizophrenia treated with aminazine and leponex were examined." | 1.27 | [Use of systematic organization of the EEG in the diagnosis of psychopathologic states]. ( Bochkarev, VK; Danilenko, IuM; Nikiforov, AI, 1983) |
| " Assessment of the pharmacokinetic parameters was provided by the use of a mathematical modelling of pharmacokinetic processes." | 1.26 | [Place of clinical and pharmacokinetic parameters in prognosing the effectiveness of schizophrenic therapy]. ( Beliaev, BS; Lukanina, SK; Minsker, EI; Panteleeva, GP; Tsirkin, SIu, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (78.87) | 18.7374 |
| 1990's | 6 (8.45) | 18.2507 |
| 2000's | 6 (8.45) | 29.6817 |
| 2010's | 3 (4.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulkarni, K | 1 |
| Arasappa, R | 1 |
| Prasad M, K | 1 |
| Zutshi, A | 1 |
| Chand, PK | 1 |
| Murthy, P | 1 |
| Philip, M | 1 |
| Muralidharan, K | 1 |
| Zhang, F | 1 |
| Kanzali, P | 1 |
| Rubin, V | 1 |
| Paras, C | 1 |
| Goldman, J | 1 |
| López-Lunar, E | 1 |
| Rodríguez-Leal, CM | 1 |
| Provencio-Arranz, RM | 1 |
| Carrascosa-Bernáldez, JM | 1 |
| Rivera-Villaverde, Á | 1 |
| Stephan, F | 1 |
| Podlipski, MA | 1 |
| Kerleau, JM | 1 |
| Petit, M | 1 |
| Guillin, O | 1 |
| Durham, RC | 1 |
| Guthrie, M | 1 |
| Morton, RV | 1 |
| Reid, DA | 1 |
| Treliving, LR | 1 |
| Fowler, D | 1 |
| Macdonald, RR | 1 |
| GERLE, B | 2 |
| BILIKIEWICZ, T | 1 |
| SULESTROWSKI, W | 2 |
| WDOWIAK, L | 2 |
| WILSON, IC | 1 |
| McKAY, J | 1 |
| SANDIFER, MG | 1 |
| Koponen, H | 1 |
| Larmo, I | 1 |
| Peer, JE | 1 |
| Rothmann, TL | 1 |
| Penrod, RD | 1 |
| Penn, DL | 1 |
| Spaulding, WD | 1 |
| Nagy, O | 1 |
| Kelemen, O | 1 |
| Erdélyi, R | 1 |
| Pataki, M | 1 |
| Janka, Z | 1 |
| Myers, CE | 1 |
| Gluck, MA | 1 |
| Kéri, S | 1 |
| Adetunji, B | 1 |
| Basil, B | 1 |
| Mathews, M | 1 |
| Osinowo, T | 1 |
| Young, MA | 1 |
| Meltzer, HY | 2 |
| Bochkarev, VK | 1 |
| Nikiforov, AI | 2 |
| Danilenko, IuM | 1 |
| Tuason, VB | 2 |
| Escobar, JI | 2 |
| Garvey, M | 1 |
| Schiele, B | 1 |
| Rifkin, A | 1 |
| Rieder, E | 1 |
| Sarantakos, S | 1 |
| Saraf, K | 1 |
| Kane, J | 1 |
| Gattaz, WF | 1 |
| Riederer, P | 1 |
| Reynolds, GP | 1 |
| Gattaz, D | 1 |
| Beckmann, H | 1 |
| Miller, FA | 1 |
| Rampling, D | 1 |
| Hansford, M | 1 |
| Eichenbaum, JW | 1 |
| D'Amico, RA | 1 |
| Bochkarov, VK | 1 |
| Tsirkin, SIu | 2 |
| Panteleeva, GP | 1 |
| Minsker, EI | 1 |
| Beliaev, BS | 1 |
| Lukanina, SK | 1 |
| Gruzelier, JH | 1 |
| Hammond, NV | 1 |
| Goldman, LS | 1 |
| Hudson, JI | 1 |
| Weddington, WW | 1 |
| Baker, RW | 1 |
| Chengappa, KN | 1 |
| Alvi, T | 1 |
| Reza, H | 1 |
| Brankovic, SB | 1 |
| Paunovic, VR | 1 |
| Bishop, MP | 1 |
| Simpson, GM | 1 |
| Dunnett, CW | 1 |
| Kiltie, H | 1 |
| McGuffin, P | 1 |
| Kay, SR | 1 |
| Singh, MM | 2 |
| Georgotas, A | 1 |
| Serra, MT | 1 |
| Green, DE | 1 |
| Perel, JM | 1 |
| Gershon, S | 1 |
| Forrest, IS | 1 |
| Forester, D | 1 |
| Greenland, P | 1 |
| Southwick, WH | 1 |
| Sikora, J | 1 |
| Krulík, R | 1 |
| Král, J | 1 |
| Novotný, J | 1 |
| Gurowitsch, IJ | 1 |
| Awruzki, GJ | 1 |
| Smeraldi, E | 1 |
| Bellodi, L | 1 |
| Sacchetti, E | 1 |
| Cazzullo, CL | 1 |
| Pfefferbaum, A | 1 |
| Berger, PA | 1 |
| Henley, SH | 1 |
| Dixon, NF | 1 |
| Wiles, DH | 1 |
| Kolakowska, T | 1 |
| McNeilly, AS | 1 |
| Mandelbrote, BM | 1 |
| Gelder, MG | 1 |
| Stevens, P | 1 |
| Schiele, BC | 1 |
| Payne, P | 1 |
| Shean, G | 1 |
| Sheppard, C | 1 |
| Beyel, V | 1 |
| Moan, E | 1 |
| Fracchia, J | 1 |
| Merlis, S | 1 |
| Govorin, NV | 1 |
| Lozhkina, AN | 1 |
| Zhang, B | 1 |
| Mackert, A | 1 |
| Woyth, C | 1 |
| Flechtner, KM | 1 |
| Volz, HP | 1 |
| Bersani, G | 1 |
| Valeri, M | 1 |
| Bersani, I | 1 |
| Piazza, A | 1 |
| Adorno, D | 1 |
| Casciani, CU | 1 |
| Ciani, N | 1 |
| Horodnicki, JM | 1 |
| Pobocha, J | 1 |
| Czekalski, S | 1 |
| Yassa, R | 1 |
| Gold, DD | 1 |
| Rinieris, P | 1 |
| Hatzimanolis, J | 1 |
| Markianos, M | 1 |
| Stefanis, C | 1 |
| Mishanich, II | 2 |
| Turianitsa, IM | 2 |
| Pashchenko, AE | 1 |
| Rostoka, LM | 2 |
| Iliushina, SN | 1 |
| Hakola, A | 1 |
| Hollister, LE | 1 |
| Overall, JE | 1 |
| Kimbell, I | 1 |
| Pokorny, A | 1 |
| Kamianov, IM | 1 |
| Kupisk, AG | 1 |
| Katsen, IZ | 1 |
| Fischer-Cornelssen, K | 2 |
| Ferner, U | 2 |
| Steiner, H | 2 |
| Avrutskii, GIa | 1 |
| Gurovich, IIa | 1 |
| Prokhorova, IS | 1 |
| Tirkel'taub, IuA | 1 |
| Romanov, IuD | 1 |
| Malakhov, BB | 1 |
| Sachar, EJ | 1 |
| Frantz, AG | 1 |
| Karimov, RK | 1 |
| Liberman, RP | 1 |
| Davis, J | 1 |
| Moon, W | 1 |
| Moore, J | 1 |
| Man, PL | 1 |
| Chen, CH | 1 |
| Briones, AV | 1 |
| Sims, A | 1 |
| White, A | 1 |
| Harding, T | 1 |
| Knight, F | 1 |
1 review available for chlorpromazine and Delusional Disorder
| Article | Year |
|---|---|
[The factors influencing the effectiveness of therapy in schizophrenia and the principles of patient selection for a comparative evaluation of the results of treatment (a survey of the literature)].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Alcoholism; Catatonia; Chlorpromazine; Chronic Diseas | 1973 |
12 trials available for chlorpromazine and Delusional Disorder
| Article | Year |
|---|---|
Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Chlorpromazine; Chronic Disease; | 2003 |
Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Dizziness | 1984 |
Is loxapine more effective than chlorpromazine in paranoid schizophrenia?
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; | 1984 |
Lateralized deficits and drug influences on the dichotic listening of schizophrenic patients.
Topics: Attention; Chlorpromazine; Dominance, Cerebral; Galvanic Skin Response; Humans; Mental Recall; Schiz | 1980 |
Efficacy of loxapine in the treatment of paranoid schizophrenia.
Topics: Adult; Brief Psychiatric Rating Scale; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; D | 1977 |
Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Topics: Adult; Anxiety; Chlorpromazine; Clinical Trials as Topic; Female; Haloperidol; Humans; Longitudinal | 1976 |
Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
Topics: Adult; Aged; Amobarbital; Analysis of Variance; Chemical Phenomena; Chemistry; Chlorpromazine; Clini | 1975 |
Pilot trials with long-acting pipotiazine injections.
Topics: Adolescent; Adult; Antipsychotic Agents; Catatonia; Chlorpromazine; Clinical Trials as Topic; Drug E | 1973 |
Specific indications for different classes of phenothiazines.
Topics: Adult; Age Factors; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; | 1974 |
[Multifocal psychopharmaceutic testing ("Multihospital trial")].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Blood Pressure; Catatonia; Chlorproma | 1974 |
[Multispectral investigation of psychotropic drugs].
Topics: Azepines; Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Drug Evaluation; Electronic Data | 1974 |
Research design for analyzing drug-environment-behavior interactions.
Topics: Adult; Behavior Therapy; Chlorpromazine; Environment; Evaluation Studies as Topic; Extinction, Psych | 1973 |
58 other studies available for chlorpromazine and Delusional Disorder
| Article | Year |
|---|---|
Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Female; Humans; Logistic Models; Male; | 2017 |
Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Chlorpromazine; Creatine Kinase; Diagnosis, Differential; | 2017 |
Prevention of Cardiac Adverse Events Associated With the Use of Drugs in Patients With Severe Mental Illness: Case Report.
Topics: Aftercare; Antipsychotic Agents; Bronchodilator Agents; Bundle-Branch Block; Chlorpromazine; Dibenzo | 2017 |
[Chlorpromazine-induced agranulocytosis: a case report].
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Drug Intera | 2009 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
Striking effects of chlorpromazine treatment in paranoid schizophrenia.
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1956 |
[Results of treatment of paranoia & paraphrenia with largactil].
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia, Paranoid | 1957 |
[Delimitation of paranoia and paraphrenia of schizophrenia].
Topics: Chlorpromazine; Humans; Paranoid Disorders; Schizophrenia; Schizophrenia, Paranoid | 1957 |
A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia.
Topics: Chlorpromazine; Double-Blind Method; Prochlorperazine; Schizophrenia; Schizophrenia, Paranoid; Tranq | 1961 |
Reversal of antipsychotic-induced weight gain during quetiapine treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain Injuries; Chlorpromazine; Dibenzothiazepines; Hu | 2003 |
Social cognitive bias and neurocognitive deficit in paranoid symptoms: evidence for an interaction effect and changes during treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Cogni | 2004 |
[Learned equivalence in schizophrenia: novel method for the measurement of memory functions of the hippocampus and basal ganglia].
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Case-Control Studies; Chlorpromazine; Dopamine Antagonis | 2005 |
Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chlorpromazine; Contraindicat | 2006 |
The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Double | 1980 |
[Use of systematic organization of the EEG in the diagnosis of psychopathologic states].
Topics: Adult; Antipsychotic Agents; Automatism; Chlorpromazine; Clozapine; Dibenzazepines; Drug Evaluation; | 1983 |
The origin and treatment of rage attacks.
Topics: Alcohol Amnestic Disorder; Anger; Chlorpromazine; Drug Interactions; Haloperidol; Humans; Male; Prop | 1984 |
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Chlorpromazine; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Norepinephrine; Schizophre | 1983 |
Adverse effects of combined propranolol and chlorpromazine therapy.
Topics: Adult; Chlorpromazine; Delirium; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Female; Humans; | 1982 |
Paranoid schizophrenia. A serpent which licked my eyes...
Topics: Chlorpromazine; Deinstitutionalization; Humans; Male; Phenothiazines; Schizophrenia, Paranoid | 1981 |
Corneal injury by a Thorazine Spansule.
Topics: Administration, Topical; Adolescent; Chlorpromazine; Female; Follow-Up Studies; Humans; Keratoconjun | 1981 |
[Electroencephalographic profile and dynamics of individual changes in the EEG of paranoid schizophrenics during treatment with aminazine (clinico-electroencephalographic correlation)].
Topics: Adult; Chlorpromazine; Electroencephalography; Humans; Male; Middle Aged; Schizophrenia, Paranoid; S | 1981 |
[Place of clinical and pharmacokinetic parameters in prognosing the effectiveness of schizophrenic therapy].
Topics: Chlorpromazine; Half-Life; Humans; Prognosis; Schizophrenia; Schizophrenia, Paranoid; Syndrome | 1980 |
Lupus-like illness associated with chlorpromazine.
Topics: Adult; Chlorpromazine; Humans; Lupus Erythematosus, Systemic; Male; Schizophrenia, Paranoid | 1980 |
Further study of neuroleptic malignant syndrome.
Topics: Adult; Chlorpromazine; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Psychia | 1995 |
Neuroleptic induced incontinence--case report.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Female; Humans; Schiz | 1997 |
Reasoning under uncertainty in deluded schizophrenic patients: a longitudinal study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Chlorpromazine; Deci | 1999 |
Is schizophrenia an HLA-associated disease?
Topics: Animals; Antigen-Antibody Reactions; Antipsychotic Agents; Chlorpromazine; Dopamine; Epitopes; HLA A | 1979 |
Cognitive abnormality in schizophrenia: a dual-process model.
Topics: Adolescent; Adult; Arousal; Attention; Chlorpromazine; Cognition Disorders; Color Perception; Concep | 1979 |
Chlorpromazine excretion. III. Fecal excretion of 14C-chlorpromzine in chronically dosed patients.
Topics: Adult; Biotransformation; Chlorpromazine; Chronic Disease; Feces; Humans; Middle Aged; Schizophrenia | 1979 |
Fatal drug-induced heat stroke.
Topics: Adult; Benztropine; Chlorpromazine; Drug Therapy, Combination; Heat Exhaustion; Humans; Male; Schizo | 1978 |
Hyperthermia associated with chlorpromazine and full-sheet restraint.
Topics: Adolescent; Body Temperature Regulation; Chlorpromazine; Fever; Humans; Male; Restraint, Physical; S | 1978 |
Chlorpromazine in the blood of schizophrenics.
Topics: Adult; Chlorpromazine; Humans; Middle Aged; Schizophrenia, Paranoid | 1978 |
[Use of triphthazine in the treatment of mentae disorders].
Topics: Chlorpromazine; Hallucinations; Humans; Long-Term Care; Mental Disorders; Psychotic Disorders; Schiz | 1975 |
The HLA system and the clinical response to treatment with chlorpromazine.
Topics: Anxiety; Binding Sites; Cell Membrane; Chlorpromazine; Depression; Histocompatibility Antigens; HLA | 1976 |
Narcolepsy, paranoid psychosis, and tardive dyskinesia: a pharmacological dilemma.
Topics: Chlorpromazine; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Imipramine; Male; Middle Aged; Narco | 1977 |
Preconscious processing in schizophrenics: an exploratory investigation.
Topics: Adult; Chlorpromazine; Consciousness; Differential Threshold; Emotions; Humans; Male; Middle Aged; P | 1976 |
Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
Topics: Acute Disease; Adult; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Fema | 1976 |
Nursing care study: paranoid schizophrenia.
Topics: Adult; Chlorpromazine; Humans; Male; Schizophrenia, Paranoid | 1976 |
Autonomic responses of paranoid, nonparanoid schizophrenic, and normal subjects to affective visual stimulation.
Topics: Adult; Arousal; Chlorpromazine; Chronic Disease; Cognition; Denial, Psychological; Diagnosis, Differ | 1975 |
Comparative survey of psychiatrists' prescription preferences: New York and Texas.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Chlorpromazine; Drug Prescriptions; Drug Therapy, Co | 1975 |
[Antibodies to neuroleptics and their role in the mechanisms of the development of drug resistance in psychopharmacotherapy of patients with paranoid schizophrenia].
Topics: Adult; Autoantibodies; Chlorpromazine; Dose-Response Relationship, Drug; Drug Resistance; Female; Ha | 1991 |
[A controlled study of clinical therapeutic effects of laser acupuncture for schizophrenia].
Topics: Acupuncture Points; Adolescent; Adult; Chlorpromazine; Double-Blind Method; Female; Humans; Laser Th | 1991 |
Increased blink rate in drug-naive acute schizophrenic patients.
Topics: Adult; Attention; Blinking; Chlorpromazine; Female; Humans; Male; Psychiatric Status Rating Scales; | 1990 |
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia.
Topics: Antipsychotic Agents; Chlorpromazine; Chromosome Mapping; Female; Gene Frequency; Haloperidol; HLA-A | 1989 |
Effect of chlorpromazine on the pituitary-adrenal functions evaluated with insulin tolerance test and dexamethasone suppression test in patients with paranoid schizophrenia.
Topics: Adult; Chlorpromazine; Dexamethasone; Humans; Hydrocortisone; Insulin; Pituitary-Adrenal System; Sch | 1989 |
Agranulocytosis in the course of phenothiazine therapy: case reports.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Female; Humans; Male; Middle Aged; Psy | 1985 |
Two misdiagnoses of disturbed ex-soldier.
Topics: Adult; Chlorpromazine; Depressive Disorder; Diagnostic Errors; Humans; Male; Mood Disorders; Pedigre | 1987 |
Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics.
Topics: Adult; Chlorpromazine; Chronic Disease; Drug Therapy, Combination; Gonadal Steroid Hormones; Humans; | 1988 |
[Free amino acids and the total middle molecule fraction of the blood serum in patients with continuously progressive paranoid schizophrenia undergoing treatment].
Topics: Adult; Aging; Amino Acids; Chlorpromazine; Drug Therapy, Combination; Humans; Middle Aged; Molecular | 1988 |
[Middle-molecule spectrum of the blood serum in patients with a continuously progressive paranoid form of schizophrenia undergoing treatment].
Topics: Chlorpromazine; Chromatography, Gel; Drug Therapy, Combination; Humans; Molecular Weight; Peptides; | 1988 |
How effective is loxapine?
Topics: Chlorpromazine; Depression; Dibenzoxazepines; Humans; Loxapine; Psychiatric Status Rating Scales; Sc | 1986 |
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Catatonia; Chlorpromazine; Facial Mus | 1973 |
[Sudden cessation of psychotropic drugs].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Blood Pressure; Chlorprom | 1974 |
[The effect of intensive hospital treatment on the duration of remissions among schizophrenics with a long history of the disease].
Topics: Ambulatory Care; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Hospitals, Psych | 1973 |
Serum prolactin levels in newly admitted psychiatric patients.
Topics: Acute Disease; Bipolar Disorder; Chicago; Chlorpromazine; Chronic Disease; Depression; Dose-Response | 1974 |
Severe shock caused by chlorpromazine hypersensitivity.
Topics: Adult; Bipolar Disorder; Blood Pressure; Chlorpromazine; Drug Hypersensitivity; Humans; Injections, | 1973 |
The dyskinetic syndrome.
Topics: Chlorpromazine; Female; Humans; Middle Aged; Movement Disorders; Schizophrenia, Paranoid | 1973 |
Coexistence of the Capgras and de Clérambault syndromes. A case history.
Topics: Adult; Affective Symptoms; Attitude; Chlorpromazine; Delusions; Female; Fluphenazine; Humans; Mother | 1973 |
Marihuana-modified mania.
Topics: Adult; Bipolar Disorder; Cannabis; Chlorpromazine; Hospitalization; Humans; Jamaica; Lithium; Male; | 1973 |